Irbesartan

CAS 138402-11-6 28 current records 13 historicalSmall Molecule

Who holds supplier records for Irbesartan? 28 organisations hold a current record for Irbesartan: an active US FDA Type II Drug Master File or a CEP. A further 13 organisations have only historical (inactive) DMF filings. 21 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (20), China (4), Netherlands (1), Hungary (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Irbesartan: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/irbesartan

Reading the evidence

  • 28 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    20 of the 27 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 15 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (28)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Irbesartan. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Irbesartan sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (21)

Certificates of Suitability on the EDQM register for Irbesartan, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 37 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
TAPI NL B.V. AmsterdamNL
CEP 2011-251 - Rev 08
Irbesartan
Oct 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2010-124 - Rev 10
Irbesartan
May 2026—
VERDANT LIFE SCIENCES PRIVATE LIMITED AnakapalliIN
CEP 2023-281 - Rev 00
Irbesartan
Feb 2026Inspected Oct 2024
Germany
SYNERGENE ACTIVE INGREDIENTS PRIVATE LIMITED HyderabadIN
CEP 2023-330 - Rev 00
Irbesartan
Jan 2026—
JUBILANT BIOSYS LIMITED MysuruIN
CEP 2011-087 - Rev 06
Irbesartan
Jan 2026—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2011-046 - Rev 07
Irbesartan
Nov 2025—
CTX LIFESCIENCES PVT. LIMITED SuratIN
CEP 2011-139 - Rev 07
Irbesartan
Nov 2025—
CPL PHARMACEUTICALS PRIVATE LIMITED AhmedabadIN
CEP 2023-237 - Rev 01
Irbesartan, Form-A
Jun 2025—
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2025-025 - Rev 00
Irbesartan, Process II
May 2025—
DIVI'S LABORATORIES LIMITED HyderabadIN
CEP 2023-404 - Rev 00
Irbesartan, Form-A
Apr 2025—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
CEP 2011-153 - Rev 05
Irbesartan
Feb 2025—
SANOFI WINTHROP INDUSTRIE GentillyFR
CEP 2024-269 - Rev 00
Irbesartan, Process II
Dec 2024—
UNICHEM LABORATORIES LIMITED MumbaiIN
CEP 2011-151 - Rev 03
Irbesartan
Nov 2024—
EUROAPI HUNGARY Ltd. BudapestHU
CEP 2020-101 - Rev 04
Irbesartan, CHINOIN
Oct 2024Inspected Jul 2026
Hungary
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2024-170 - Rev 00
Irbesartan, Form A
Aug 2024—
HETERO LABS LIMITED HyderabadIN
CEP 2017-104 - Rev 04
Irbesartan
Mar 2024—
ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Zhuhai CityCN
CEP 2017-151 - Rev 05
Irbesartan
Mar 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2021-297 - Rev 01
Irbesartan, Process II
Dec 2023—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
R1-CEP 2010-195 - Rev 08
Irbesartan
Apr 2023—
MSN LIFE SCIENCES PRIVATE LIMITED Chandampet VillageIN
R0-CEP 2021-351 - Rev 00
Irbesartan
Jan 2023—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
R1-CEP 2010-033 - Rev 03
Irbesartan
May 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (13)

Organisations whose Type II DMFs for Irbesartan are no longer active. These show a past filing, not current supply.

Show all 13 historical records

Overview

Irbesartan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1513).

Chemical identity

IUPAC name
2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
Canonical SMILES
CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
InChIKey
YOSHYTLCDANDAN-UHFFFAOYSA-N
Synonyms
Aprovel, Avapro, BMS-186295, Ifirmasta, Irbesartan, Irbesartan bms, Irbesartan component of avalide, Irbesartan component of coaprovel, Irbesartan component of ibersartan/hydrochlorothiazide ibersartan, Irbesartan component of ibersartan/hydrochlorothiazide teva ibersartan, Irbesartan component of ibersartan/hydrochlorothiazide zentiva ibersartan, Irbesartan component of ifirmacombi

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Angiotensin 2 Receptor Blocker
Mechanism of action
Angiotensin 2 Receptor Antagonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Irbesartan?

28 organisations hold an active US FDA Type II Drug Master File or a CEP for Irbesartan: TAPI NL BV (Netherlands), Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), Divis Laboratories (India), Dr. Reddy's Laboratories Ltd. (India), EUROAPI HUNGARY LTD (Hungary), Hetero Labs Limited (India) and JUBILANT BIOSYS LTD (India), and 20 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Irbesartan Drug Master Files are active?

TAPI NL BV (DMF 17394, 25483), Alembic Pharmaceuticals Limited (DMF 20378), APITORIA PHARMA PRIVATE LTD (DMF 23084), Divis Laboratories (DMF 39096, 26418), Dr. Reddy's Laboratories Ltd. (DMF 20008), EUROAPI HUNGARY LTD (DMF 19690), Hetero Labs Limited (DMF 17507, 24665) and JUBILANT BIOSYS LTD (DMF 19790) and 14 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Irbesartan records mean?

13 organisations have only inactive Type II DMFs for Irbesartan. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Irbesartan have a European Certificate of Suitability?

Yes. 21 organisations hold a valid CEP for Irbesartan on the EDQM register, including TAPI NL B.V. Amsterdam (NL), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), VERDANT LIFE SCIENCES PRIVATE LIMITED Anakapalli (IN), SYNERGENE ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad (IN), JUBILANT BIOSYS LIMITED Mysuru (IN) and MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN) and 15 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Irbesartan supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Irbesartan?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.